Prince Bahadursingh – Cipla
View Detailed Executive Profile →Professional Overview
- Prince Bahadursingh founded Cipla, a leading global pharmaceutical company, with a vision to provide affordable healthcare.
- Cipla played a pivotal role in the generics market, significantly reducing medication costs and increasing access to essential drugs.
- The company was among the first to manufacture and distribute anti-AIDS drugs for the developing world, demonstrating a commitment to social responsibility.
- Cipla's international collaborations helped expand its reach, introducing various pharmaceutical innovations across multiple markets.
- The organization's dedication to research and development led to breakthroughs in areas such as respiratory and cardiac treatments.
- Prince Bahadursingh faced challenges in navigating regulatory environments, yet successfully established Cipla as a trusted name in pharmaceuticals.
- The company was recognized globally for its contributions to public health, earning numerous awards and accolades for excellence in the pharmaceutical industry.
- Cipla's corporate ethos emphasized sustainability and ethical practices, reinforcing its reputation as a socially responsible corporation.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Cipla | Founder | Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Cipla corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Prince Bahadursingh's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Cipla's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)